课题基金 / 基金详情

Development of methods to inhibit apoptosis induced by intracellular amyloid β-protein in Alzheimer's disease

Development of methods to inhibit apoptosis induced by intracellular amyloid β-protein in Alzheimer's disease
开发抑制阿尔茨海默病细胞内β淀粉样蛋白诱导的细胞凋亡的方法
批准号:
18590948
负责人:
OHYAGI Yasumasa
金额:
$2.49万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2006
资助国家:
日本
项目状态:
已结题
起止时间:
2006 至 2007

项目摘要

项目成果

OHYAGI Yasumasa的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
It is known as "amyloid hypothesis" that extracellular amyloid β-protein (Aβ) is neurotoxic in Alzheimer's disease (AD). While, intraneuronal Aβ accumulation is recently suggested to be neurotoxic. We have found apomorphine sulf ate (APO) to enhance intracellular Aβ degradation. Also, we found that APO protected neurons markedly from oxida tive stress induced by hydrogen peroxide. Furthermore, protective effects of APO were remarkable against oxidative stress and these effects were mediated by elevation of glutathione peroxidase (GPx) activity.We further investigated therapeutic efficacy of APO on an AD mouse model. 3XTg mice, which had two familial AD-related mutant genes (APP-KM670/671NL and PS1-M146V) and a mutation of Tau P301L, demonstrated intrane uronal Aβ accumulation, hyperphosphorylated tau accumulation and memory disturbance at the age of 4 months. Af ter subcutaneous injection of APO at 5 mg/kg once a week until 4 weeks, short-term memory evaluated by Morris water maze test was significantly improved. In pathological study, intraneuronal accumulation of Aβ and hyperphosp horylated tau was very mild in APO-injected mice brain. Accordingly, APO was not only cell protective against oxid ative damage-induced apoptosis but also effective on cognitive dysfunction and pathological change in AD mouse mo del, and proved to be a powerful candidate drug for AD patients.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Intracellular amyloid β-protein and its associated molecules in the pathogenesis of Alzheimer's disease
细胞内β淀粉样蛋白及其相关分子在阿尔茨海默病发病机制中的作用
DOI: --
发表时间: 2006
期刊: Mini-Reviews in Medicinal Chemistry 6
影响因子: --
作者: [Ohvagi, Y, Tabira, T]
通讯作者: T
アルツハイマー病の分子病態と治療-特にアミロイドβ蛋白を標的として-
阿尔茨海默氏病的分子病理学和治疗 - 特别是针对淀粉样β蛋白 -
DOI: --
发表时间: 2006
期刊: 福岡医学雑誌 97・9
影响因子: --
作者: [Ohyagi Y, Tabira T, 大八木保政, 大八木保政]
通讯作者: 大八木保政
DOI: 10.1016/j.jneumeth.2006.06.010
发表时间: 2007-01
期刊: Journal of Neuroscience Methods
影响因子: 3
作者: [Y. Ohyagi;Y. Tsuruta;K. Motomura;Katsue Miyoshi;H. Kikuchi;T. Iwaki;T. Taniwaki;J. Kira]
通讯作者: Y. Ohyagi;Y. Tsuruta;K. Motomura;Katsue Miyoshi;H. Kikuchi;T. Iwaki;T. Taniwaki;J. Kira
アルツハイマー病の予防・治療剤
阿尔茨海默病的预防和治疗
DOI: --
发表时间: 2007
期刊:
影响因子: --
作者: []
通讯作者:
13
    Development of apomorphine therapy for Alzheimer disease
    • 批准号:
      22590936
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.91万
    • 财政年份:
      2010
    • 负责人:
      OHYAGI Yasumasa
    • 依托单位:
    Search for the proteins linked to Alzheimer's disease-specific neuronal death and application for the therapeutics.
    • 批准号:
      13670651
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.3万
    • 财政年份:
      2001
    • 负责人:
      OHYAGI Yasumasa
    • 依托单位:
    海外基金